[Federal Register Volume 61, Number 170 (Friday, August 30, 1996)]
[Notices]
[Page 45986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22218]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 15, 1995, Celgene 
Corporation, 7 Powder Horn Drive, Warren, NJ 07059, made application to 
the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)...............................       I  
Amphetamine (1100)............................................      II  
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of 2,5-
dimethoxyamphetamine using biocatalysis to develop, manufacture and 
sell high value added compounds to pharmaceutical and agrochemical 
industries and amphetamine for distribution of the bulk active 
substances to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, U.S. Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 29, 1996.

    Dated: August 21, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-22218 Filed 8-29-96; 8:45 am]
BILLING CODE 4410-09-M